Verastem Inc (VSTM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.72
• Market Cap: $439.11M
• EPS: $-4.28
• 52-Week High: $11.25
• 52-Week Low: $4.01

Market Sentiment

Verastem Inc currently has a Neutral sentiment score of 0.14.

About Verastem Inc

Verastem Inc. is a clinical-stage biopharmaceutical company headquartered in Needham, Massachusetts, dedicated to developing and commercializing innovative therapies for patients battling cancer. With a particular focus on addressing unmet medical needs through its proprietary drug candidates, Verastem aims to enhance the quality of life and improve clinical outcomes for cancer patients. The company's robust pipeline includes targeted therapies designed to overcome treatment resistance and im...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Verastem Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VSTM pay dividends?

Verastem Inc (VSTM) does not currently pay a regular dividend.

What is VSTM's market cap?

Verastem Inc (VSTM) has a market capitalization of $439.11M with a current stock price of $5.72.